business

AstraZeneca advances weight-loss pill to take aim at obesity leaders

Financial Times · Jun 8, 2026, 8:15 PM · Also reported by 1 other source

Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly

Read full story on Financial Times → More top stories

Also covered by

STAT News STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials

Aggregated and edited by the Scoop newsroom. We surface news from Financial Times alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

AstraZeneca advances weight-loss pill to take aim at obesity leaders

Also covered by

More in business